Economic development programs have always played an important role in boosting the U.S. biotech industry. When a company has to invest years and millions of dollars just to get started, it needs every advantage it can lay its hands on. Throw in a recession and a severe cash crunch that seemingly forces another developer into liquidation every few days, and the role of economic development becomes much, much more important.
Every spring FierceBiotech pours over a year's worth of economic development reports to find new initiatives that have a real chance to spark a burst of new biotech activity. Whether it's new money to spur research, a critical element in fostering new biotech companies, or direct and innovative support for developers, the regions we choose are stepping up with fresh ideas that have the potential to breed or expand biotech clusters. Take a look at this year's list to learn which regions are offering the best programs to attract drug developer. Report